Cetrorelix Acetate

Suppliers

Names

[ CAS No. ]:
145672-81-7

[ Name ]:
Cetrorelix Acetate

Chemical & Physical Properties

[ Molecular Formula ]:
C₇₂H₉₆ClN₁₇O₁₆

[ Molecular Weight ]:
1491.09000

[ Exact Mass ]:
1489.69000

[ PSA ]:
532.97000

[ LogP ]:
6.02320

[ Storage condition ]:
-20°C

Safety Information

[ Symbol ]:

GHS08

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H361

[ Precautionary Statements ]:
P281

[ RIDADR ]:
NONH for all modes of transport

Articles

Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency.

Hum. Reprod. 30(3) , 608-15, (2015)

Is ovarian tissue cryopreservation using vitrification followed by in vitro activation (IVA) of dormant follicles a potential approach for infertility treatment of patients with primary ovarian insuff...

Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience.

J. Assist. Reprod. Genet. 32(4) , 587-96, (2015)

To compare the in-vitro fertilization (IVF) outcomes of cancer patients who underwent oocyte retrieval and embryo/oocyte cryopreservation prior to gonadotoxic therapy to those of age and time-matched ...

Sperm morphological normality under high magnification predicts laboratory and clinical outcomes in couples undergoing ICSI.

Hum. Fertil. (Camb.) 18 , 81-6, (2015)

The objective of this study was to evaluate whether 'motile sperm organelle morphology examination' (MSOME) is correlated with the outcome of ICSI. A total of 14400 spermatozoa from 72 couples undergo...

Cetrorelix acetate
Cetrorelix acetate
chrysanthenyl acetate
Glutinol acetate
Menthyl acetate
isoprenyl acetate
rac-1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl (1R,2R)-2-[2-(trifluoromethyl)phenyl]cyclopropane-1-carboxylate
rac-1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl (1R,2R)-2-(furan-2-yl)cyclopropane-1-carboxylate
rac-1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl (1R,2R)-2-(pyridin-3-yl)cyclopropane-1-carboxylate
(2S)-2-{[5-(aminomethyl)-2-fluorophenyl]formamido}-4,4-dimethyl-N-(6-methylpyridazin-3-yl)pentanamide
(3'E,9'R,10'R)-9',10'-dimethyl-2',5',7',8',9',10',11',12'-octahydrospiro[azetidine-3,6'-[1,8,11]benzoxadiazacyclotetradecin]-3'-ene-7',12'-dione; trifluoroacetic acid
(3E,10S)-10-methyl-2,5,7,8,9,10,11,12-octahydrospiro[1,8,11-benzoxadiazacyclotetradecine-6,1'-cyclopentan]-3-ene-7,12-dione
(3E,10S)-6-benzyl-10-methyl-5,6,7,8,9,10,11,12-octahydro-2H-1,8,11-benzoxadiazacyclotetradecine-7,12-dione
3-Bromo-2-(ethanesulfonyl)benzoic acid
1-(3-Bromo-6-methylpyridin-2-yl)methanamine dihydrochloride
tert-butyl 4-(4-{[(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)oxy]carbonyl}oxan-4-yl)-1,2,3,6-tetrahydropyridine-1-carboxylate

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.